Comorbidity Influence on Postoperative Outcomes Following Anterior Cervical Discectomy and Fusion

Objective: This study aims to detail the association between comorbidity burden and achieving minimum clinically important difference (MCID) following anterior cervical discectomy and fusion (ACDF). Methods: A prospective surgical registry was retrospectively reviewed. Patients with missing preoperative Patient-Reported Outcomes Measurement Information System physical function (PROMIS PF) were excluded. Patients were stratified by Charlson Comorbidity Index (CCI): no comorbidities=0 point; low CCI=1-2 points; high CCI=>= 3 points. Demographic and perioperative characteristics were collected and evaluated for differences. Visual analogue scale (VAS), 12-item Short Form health survey (SF-12), and PROMIS PF were collected pre- and postoperatively and assessed for differences. Differences in achievement of MCID were compared using established values: VAS neck=2.6, VAS arm=4.1, NDI=8.5, SF-12 physical composite score (SF-12 PCS)=8.1, PROMIS PF=4.5. Results: One hundred twenty-five ACDF patients were included: 37 had no comorbidities, 64 with low CCI, and 24 with high CCI. Higher CCI groups were older, nonsmokers, diabetic, arthritic, hypertensive, and had cancer. Multilevel fusions, operative time, length of stay, and later discharge day were associated with high CCI. VAS neck differed preoperatively by group. SF-12 PCS and PROMIS PF were inversely associated with CCI groups. CCI did not impact achievement of MCID for all outcomes. A lower rate of reaching MCID was demonstrated at 3 months for SF-12 PCS. Conclusion: Regardless of comorbidity burden, patients undergoing ACDF for cervical pathology demonstrated a similar rate of achieving MCID for VAS neck, VAS arm, NDI, and PROMIS PF. Regardless of CCI score, ACDF can have a significant benefit for patients.

Automated summary

This study found that patients undergoing anterior cervical discectomy and fusion (ACDF) for cervical pathology achieved similar rates of reaching minimum clinically important difference (MCID) for VAS neck, VAS arm, NDI, and PROMIS PF regardless of comorbidity burden. ACDF can have significant benefits for patients regardless of their Charlson Comorbidity Index (CCI) score.